Genetic predisposition to acute kidney injury induced by severe sepsis

Journal of Critical Care

Volumn 28, Issue 4, 2013, Pages 365-370

  Cardinal Fernández, Pablo ^a,b   Ferruelo, Antonio ^a,b   El Assar, Mariam ^a,b   Santiago, Catalina ^c   Gómez Gallego, Félix ^c   Martín Pellicer, Ana ^a,b   Frutos Vivar, Fernando ^a,b   Peñuelas, Oscar ^a,b   Nin, Nicolás ^a,b,c,d   Esteban, Andrés ^a,b   Lorente, José A ^a,b,c  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^c UNIVERSIDAD EUROPEA DE MADRID   (Spain)

^d HOSPITAL UNIVERSITARIO DE TORREJÓN   (Spain)

Author keywords

Acute kidney injury; Genetic predisposition; Polymorphism; Severe sepsis; Vascular endothelial growth factor

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; GENOMIC DNA; INTERLEUKIN 8; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; GENE DELETION; GENE INSERTION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; HYPERTENSION; INFORMED CONSENT; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; SCORING SYSTEM; SEPSIS; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; APACHE; CHI SQUARE DISTRIBUTION; GENETICS; MIDDLE AGED; NONPARAMETRIC TEST; POLYMORPHISM; RISK FACTOR; SEVERE SEPSIS; STATISTICS;

ACUTE KIDNEY INJURY; GENETIC PREDISPOSITION; POLYMORPHISM; SEVERE SEPSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR;

ACUTE KIDNEY INJURY; AGED; APACHE; CHI-SQUARE DISTRIBUTION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK FACTORS; SEPSIS; STATISTICS, NONPARAMETRIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84886669259     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2012.11.010     Document Type: Article

References (29)

1. de Mendonca A., Vincent J.L., Suter P.M., et al. Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score. Intensive Care Med 2000, 26:915-921.
2. Cardinal-Fernandez P., Ferruelo A., Martin-Pellicer A., et al. Genetic determinants of acute renal damage risk and prognosis: a systematic review. Medicina Intensiva 2012, 36:626-633.
3. Popov A.F., Hinz J., Schulz E.G., et al. The eNOS 786C/T polymorphism in cardiac surgical patients with cardiopulmonary bypass is associated with renal dysfunction. Eur J Cardiothorac Surg 2009, 36:651-656.
4. Popov A.F., Schulz E.G., Schmitto J.D., et al. Relation between renal dysfunction requiring renal replacement therapy and promoter polymorphism of the erythropoietin gene in cardiac surgery. Artif Organs 2010, 34:961-968.
5. MacKensen G.B., Swaminathan M., Ti L.K., et al. Preliminary report on the interaction of apolipoprotein E polymorphism with aortic atherosclerosis and acute nephropathy after CABG. Ann Thorac Surg 2004, 78:520-526.
6. Haase-Fielitz A., Haase M., Bellomo R., et al. Decreased catecholamine degradation associates with shock and kidney injury after cardiac surgery. J Am Soc Nephrol 2009, 20:1393-1403.
7. Isbir S.C., Tekeli A., Ergen A., et al. Genetic polymorphisms contribute to acute kidney injury after coronary artery bypass grafting. Heart Surg Forum 2007, 10:E439-E444.
8. Stafford-Smith M., Podgoreanu M., Swaminathan M., et al. Association of genetic polymorphisms with risk of renal injury after coronary bypass graft surgery. Am J Kidney Dis 2005, 45:519-530.
9. Jaber B.L., Rao M., Guo D., et al. Cytokine gene promoter polymorphisms and mortality in acute renal failure. Cytokine 2004, 25:212-219.
10. Perianayagam M.C., Liangos O., Kolyada A.Y., et al. NADPH oxidase p22phox and catalase gene variants are associated with biomarkers of oxidative stress and adverse outcomes in acute renal failure. J Am Soc Nephrol 2007, 18:255-263.
11. Kolyada A.Y., Tighiouart H., Perianayagam M.C., Liangos O., Madias N.E., Jaber B.L. A genetic variant of hypoxia-inducible factor-1alpha is associated with adverse outcomes in acute kidney injury. Kidney Int 2009, 75:1322-1329.
12. Alam A., O'Connor D.T., Perianayagam M.C., et al. Phenylethanolamine N-methyltransferase gene polymorphisms and adverse outcomes in acute kidney injury. Nephron Clin Pract 2010, 114:c253-c259.
13. Payen D., Lukaszewicz A.C., Legrand M., et al. A multicentre study of acute kidney injury in severe sepsis and septic shock: association with inflammatory phenotype and HLA genotype. PLoS One 2012, 7:e35838.
14. du Cheyron D., Fradin S., Ramakers M., et al. Angiotensin converting enzyme insertion/deletion genetic polymorphism: its impact on renal function in critically ill patients. Crit Care Med 2008, 36:3178-3183.
15. Cardinal-Fernandez P., Nin N., Lorente J.A. Acute lung injury and acute respiratory distress syndrome: a genomic perspective. Med Intensiva 2011, 35:361-372.
16. Ostermann M., Chang R.W. Acute kidney injury in the intensive care unit according to RIFLE. Crit Care Med 2007, 35:1837-1843. [quiz 52].
17. Bernard G.R., Artigas A., Brigham K.L., et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994, 149:818-824.
18. Murray P., Hall J. Renal replacement therapy for acute renal failure. Am J Respir Crit Care Med 2000, 162:777-781.
19. Rigat B., Hubert C., Alhenc-Gelas F., et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990, 86:1343-1346.
20. Doi K., Noiri E., Nakao A., et al. Functional polymorphisms in the vascular endothelial growth factor gene are associated with development of end-stage renal disease in males. J Am Soc Nephrol 2006, 17:823-830.
21. Medford A.R., Keen L.J., Bidwell J.L., et al. Vascular endothelial growth factor gene polymorphism and acute respiratory distress syndrome. Thorax 2005, 60:244-248.
22. Zhai R., Gong M.N., Zhou W., et al. Genotypes and haplotypes of the VEGF gene are associated with higher mortality and lower VEGF plasma levels in patients with ARDS. Thorax 2007, 62:718-722.
23. Renner W., Kotschan S., Hoffmann C., et al. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res 2000, 37:443-448.
24. Isman F.K., Zulfikaroglu B., Acar A., et al. Serum visfatin levels in acute appendicitis. Int J Surg 2010, 8:259-260.
25. Axelsson J., Witasp A., Carrero J.J., et al. Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD. Am J Kidney Dis 2007, 49:237-244.
26. Bajwa E.K., Yu C.L., Gong M.N., et al. Pre-B-cell colony-enhancing factor gene polymorphisms and risk of acute respiratory distress syndrome. Crit Care Med 2007, 35:1290-1295.
27. Bates D.O., Hillman N.J., Williams B., et al. Regulation of microvascular permeability by vascular endothelial growth factors. J Anat 2002, 200:581-597.
28. Hildebrand F., Stuhrmann M., van Griensven M., et al. Association of IL-8-251A/T polymorphism with incidence of acute respiratory distress syndrome (ARDS) and IL-8 synthesis after multiple trauma. Cytokine 2007, 37:192-199.
29. Simmons E.M., Himmelfarb J., Sezer M.T., et al. Plasma cytokine levels predict mortality in patients with acute renal failure. Kidney Int 2004, 65:1357-1365.